Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models

发表于 2026-8-20 15:27:27

期刊：Journal of Medicinal Chemistry

文献作者：Guillaume Dutheuil; Killian Oukoloff; Julien Korac; Francois Lenoir; Mohamed El Bousmaqui; Nicolas Probst; Alexey Lapin; Galina Nakhabina; Catherine Sorlet; Nicolas Parmentier; Delphine Karila; Nugzar Ghavtadze; Paméla Casault; Stephen Claridge; Selma Sapmaz; Martin J. Slater; Graeme L. Fraser

出版日期：2025-2-13

DOI号：10.1021/acs.jmedchem.4c02225

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c02225

文献链接：https://doi.org/10.1021/acs.jmedchem.4c02225

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 2026-8-20 15:27:28

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models 一键复制